Recent Advances in Pharmaceutical Formulation
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 1947
Special Issue Editors
Interests: pharmaceutical formulation
Interests: hydrogels; oleogels; bigels; pharmaceutical formulation; orodispersible tablets
Special Issues, Collections and Topics in MDPI journals
Interests: pharmaceutical development; innovative dosage forms; 3D printing in pharmaceutics; quality by design (QbD); process analytical technology (PAT); multivariate data analysis (MVDA); pharmaceutical product/process optimization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pharmaceutical formulation represents a vital and deeply influential stage in the development of any medicinal product. The precision, creativity, and scientific rigor applied at this point shape not only the success of subsequent research and clinical phases, but also the real-world impact felt by patients. As the need for truly personalized therapies continues to grow, the limitations of standardized industrial products become increasingly evident. Patients bring with them unique biological profiles- genetic test results, intolerances, variable responses to therapy, making individualized approaches not just desirable, but often essential. In this evolving landscape, magistral and compounded preparations are re-emerging as highly adaptable solutions capable of meeting needs that industrial manufacturing cannot. From capsules tailored to patients with specific intolerances, to dermatological formulations using transdermal bases, to ovules containing thermolabile compounds impossible to mass produce, these practices highlight the remarkable versatility and human-centered value of pharmaceutical compounding. They also cultivate a distinct professional space for pharmacists whose laboratory expertise bridges scientific precision with artisanal care.
In recent years, this field has expanded significantly, particularly within individualized therapies informed by genetic testing. Such advances allow for the fine-tuning of treatments in ways previously unattainable. Within this framework, magistral compounding has emerged as a powerful and responsive tool, enabling the exact balancing of a formulation according to the optimal efficacy profile of an active substance as determined through genetic analysis. Personalized therapies are increasingly recognized not only as a scientific advancement, but as a profound contributor to patient well-being and professional fulfilment, providing physicians, patients, and pharmacists alike with a sense of trust, collaboration, and shared success.
This Special Issue aims to bring together innovative research contributions and thoughtful critical reviews focused on the formulation of personalized and compounded preparations. Areas of interest include sustainable excipients, preformulated bases, advanced drug-delivery platforms, and strategies for effectively adapting formulations to individual therapeutic needs. By weaving together traditional pharmaceutical craftsmanship with modern technological progress, this volume aspires to advance the field of pharmaceutical formulation in both academic discourse and clinical practice, always with the ultimate goal of improving patient care.
Dr. Magdalena Bîrsan
Dr. Robert-Alexandru Vlad
Prof. Dr. Ioan Tomuta
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sustainable excipients
- preformulated bases
- drug delivery platforms
- pharmaceutical formulation
- personalized therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
